Image 1-min

What It Takes for a Winning QuickFire Challenge Entry

mildred Uncategorised Leave a Comment

Johnson & Johnson Innovation believes the best way to advance innovation is through collaboration, because great ideas can come from anywhere and anyone. Through Johnson & Johnson Innovation’s open innovation model, early stage innovators have the opportunity of working with some of the brightest minds around the world to accelerate solutions for unmet healthcare needs.

The global JLABS QuickFire Challenges are examples of how Johnson & Johnson Innovation initiates collaborations across international borders. They support working with local partners for innovation and empower innovative scientists, companies and entrepreneurs to seek comprehensive and integrated solutions that hold the potential of improving the health of people around the world, particularly in areas of significant global impact on people’s health.

These competitions call for early-stage innovators to apply for a chance to win research grants, access to world-class lab spaces, exposure to the innovation community and other startups, global industry networking opportunities, mentorship and coaching from Johnson & Johnson Innovation and its partners, and more.

Past QuickFire Challenges

To date, Johnson & Johnson Innovation has successfully carried out 10 QuickFire Challenges in numerous countries across the globe, and awarded 24 winners in total. More importantly, the Challenges have attracted applications from a range of backgrounds and healthcare focus areas. Past winners of the QuickFire Challenges include innovators from different geographies, academia, institutions, and companies.

In June 2016, a recipient from Alberto Luiz Coimbra Institute of Graduate Studies and Engineering Research, Federal University of Rio de Janeiro won the Latin America QuickFire Challenge for her cutting-edge Zika virus research. The winner was awarded six months of residency at the JLABS @ TMC incubator in Houston, Texas. In Queensland, Australia, recipients Golden Biotechnology Corporation, Atomo Diagnostics, and Eikonic R&D Pty Ltd. won the Advance Queensland QuickFire Challenge and received AUD100,000 each, as well as access to mentorship and coaching from Johnson & Johnson staff.

Later on in the year, Johnson & Johnson Innovation launched its biggest and most ambitious Challenge, the World Without Disease QuickFire Challenge, where recipients from RMIT University, Glyscend, Inc., and Neurotrack received a US$500,000 research grant and residency at one of Johnson & Johnson Innovation’s JLABS. The three winners were selected from over 470 global applicants.

All of these QuickFire Challenges represent an ongoing commitment to support diverse life science innovations and the development of integrated, cross-sector solutions to prevent, intercept and cure diseases. Johnson & Johnson Innovation has worked closely with these grant recipients to support their early-stage ideas and innovation, with the goal of delivering advanced solutions to patients in need.

Who Can Join the QuickFire Challenge?

Each and every QuickFire Challenge is unique with the ultimate aim to attract game-changing early-stage innovation across Johnson & Johnson Innovation’s strategic areas of interest. If you are an entrepreneur, academic or biotech researcher with cutting-edge solutions for pressing healthcare issues, we want to hear it.

Johnson & Johnson Innovation encourages everyone who has an entrepreneurial and creative spirit to join the Challenge.

137086430-1-min (1)

The Latest, and First Asia-proper QuickFire Challenge in Singapore

With key demographic shifts such as the rapidly growing middle class, ageing population, and surges in chronic diseases, healthcare challenges in the region are more pressing than ever. Johnson & Johnson Innovation understands the urgency to tackle today’s most pressing diseases and is committed to work with local partners and innovators to tackle the major threat of metabolic disease in the area.

To see this commitment through, Johnson & Johnson Innovation launched the JLABS Singapore QuickFire Challenge – Metabolic Disease Innovation in partnership with ETPL and Singapore MIT Alliance for Research and Technology (SMART). The Challenge, with support from SPRING Singapore, seeks solutions that address metabolic diseases such as diabetes or obesity, and supports to strengthen Singapore as a key innovation hub in Asia Pacific.

Applications are now closed and winners will be announced between 19 and 21 September 2017.

For more information about Johnson & Johnson Innovation and QuickFire Challenges, please visit jlabs.jnjinnovation.com/quickfire-challenges.

Leave a Reply

Your email address will not be published. Required fields are marked *